Last updated: 2026-10-06 05:19:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Bluejay Diagnostics, Inc. (BJDX) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $0.77, with a market capitalization of $865.64K and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.76 to $16.68. This page covers its latest market performance, valuation, price trends and company information.
$865.64K | |
$0.84 | |
$200,000.00 | |
$0.76 | |
$0.84 | |
383.74K | |
5.22M | |
-- | |
$16.68 | |
$0.76 | |
-- | |
-- |
Bluejay Diagnostics, Inc. (BJDX) last closed at $0.84 as of 2026-10-05 23:59:00, unchanged from the previous close of $0.84.
During the latest regular trading session, BJDX traded between $0.76 and $200,000.00, with a volume of 383.74K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Bluejay Diagnostics, Inc. (BJDX) moved from $0.95 to $0.77, representing a decline of 18.95% ($0.18).
The stock traded between $0.76 and $0.99 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 225.34 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 0.1%
BJDX is currently trading at $0.77, placing it 0.1% of the way from its 52-week low of $0.76 to its 52-week high of $16.68. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 6 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Bluejay Diagnostics, Inc. (BJDX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.